Search - tctmd.com

Displaying 341 - 360 of 777

Sort: Relevancy | Date

Presentation TVT 2021

Trans-Apical Systems: Clinical Experiences in Large RCTs and Registries

Presenter: Martin Leon

July 21, 2021

Presentation TVT 2021

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

Presenter: Ming-yu (Anthony) Chuang

July 21, 2021

Presentation TVT 2021

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

Presenter: Jörg Hausleiter

July 21, 2021

Presentation TVT 2021

Case Resolution: LVOT Obstruction After Mitral ViMAC

Presenter: Mayra Guerrero

July 20, 2021

Presentation TVT 2021

Case Introduction: LVOT Obstruction After Mitral ViMAC

Presenter: Mayra Guerrero

July 20, 2021

Presentation TVT 2021

Case Resolution: Late Symptomatic Mitral Stenosis After TEER

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Introduction: Late Symptomatic Mitral Stenosis After TEER

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Resolution: Residual ASD After TEER

Presenter: Howard Herrmann

July 20, 2021

Presentation TVT 2021

Case Introduction: Residual ASD After TEER

Presenter: Howard Herrmann

July 20, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

Presenter: Gilbert Tang

July 20, 2021

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

Presentation TVT 2020

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Presenter: Gennaro Giustino

June 21, 2020

Presentation TVT 2020

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Presenter: Tsuyoshi Kaneko

June 21, 2020

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

Advertisement

Trans-Apical Systems: Clinical Experiences in Large RCTs and Registries

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

Case Resolution: LVOT Obstruction After Mitral ViMAC

Case Introduction: LVOT Obstruction After Mitral ViMAC

Case Resolution: Late Symptomatic Mitral Stenosis After TEER

Case Introduction: Late Symptomatic Mitral Stenosis After TEER

Case Resolution: Residual ASD After TEER

Case Introduction: Residual ASD After TEER

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Device Explants After TAVR Rare but Risky

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content